Navigation Links
Exposure to stress even before conception causes genetic changes to offspring
Date:7/8/2013

A female's exposure to distress even before she conceives causes changes in the expression of a gene linked to the stress mechanism in the body in the ovum and later in the brains of the offspring from when they are born, according to a new study on rats conducted by the University of Haifa.

"The systemic similarity in many instances between us and mice raises questions about the transgenerational influences in humans as well, for example, the effects of the Second Lebanon War or the security situation in the South on the children of those who went through those difficult experiences," the researchers said. "If until now we saw evidence only of behavioral effects, now we've found proof of effects at the genetic level."

In previous studies in Prof. Micah Leshem's lab, it was found that exposing rats to stress before they had even conceived (and even at their "teen" stage) influences the behavior of their offspring. This study, conducted in the lab of Dr. Inna Gaisler-Salomon by PhD student Hiba Zaidan, in cooperation with Prof. Leshem, the researchers sought to examine whether there was an influence on genetic expression.

In the study, which was recently published in the journal Biological Psychiatry, the researchers focused on the gene known as CRF-1, a gene linked to the body's stress-control system that expresses itself in many places in the brain under stress.

The researchers took female rats that were 45 days old, which is parallel to human adolescence. Some of the rats were exposed to "minor" stress, which included changes in temperature and daily routine for seven days, and compared them to a control group that was not exposed to stress at all. The rats were mated and conceived two weeks later.

In the first part of the study, the researchers examined the ova of the rats that were exposed to stress even before they conceived, and they found that at that stage there was enhanced expression of the CRF-1 gene. For the second part,
'/>"/>

Contact: Polina Petruhin
ppetruh1@univ.haifa.ac.il
972-543-933-092
University of Haifa
Source:Eurekalert

Page: 1 2

Related medicine news :

1. C8 Lawsuit Lawyers at Wright & Schulte LLC Report on Growing Litigation Over Exposure to C8 Tainted Drinking Water from DuPont’s Washington Works Plant
2. Virginia Surgeon Dr. Mark W. McFarland Uses SpineFrontier’s Less Exposure Surgery Technologies: the New Invue Inset Trial-Cage Drill Guide and the Low-Profile Invue Inset
3. C8 Lawsuit News: Wright & Schulte LLC Launches C8 Facebook Page to Provide Up-to-Date Information On C8 Exposure and C8 Lawsuits in Ohio and West Virginia
4. Exposure to BPA in developing prostate increases risk of later cancer
5. Exposure to low doses of BPA linked to increased risk of prostate cancer in human stem cells
6. Cutting-Edge 3-D Technology at Midtown Dentistry Reduces Patient X-Ray Exposure
7. TCE exposure linked to increased risk of some cancers
8. Pesticide Exposure May Raise Parkinsons Risk, Study Suggests
9. Hidden Beach, the Only Luxurious All-inclusive Nudist Resort in the Mexican Caribbean, to Host Social Exposure's Naked Painting Party, Announces Go Classy Tours
10. Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study
11. Early-life traffic-related air pollution exposure linked to hyperactivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... NJ (PRWEB) , ... July 30, 2015 , ... ... Jersey's State-designated entity on behalf of the New Jersey Department of Health, has ... Health Information Technology, an agency of the U.S. Department of Health and Human ...
(Date:7/30/2015)... ... July 30, 2015 , ... 1Heart Caregiver Services LLC is offering its ... Make Money in the Booming Homecare Business.” This will be held in its main ... , The event will be hosted by 1Heart’s very own Randy Clarito (Director of ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... After a ... Argus II retinal implant, more commonly known as the “bionic eye,” researchers have determined ... safe and viable tool for patients facing or already affected by complete vision loss ...
(Date:7/30/2015)... Santa Rosa, CA (PRWEB) , ... July 30, 2015 , ... At the presentation of ... topic of discussion was focused on research presented by the Journal of Arthroplasty ... normal tasks – like driving. , Results of the study confirm what Santa ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... for women to ensure their children have the nutrition required to grow into ... by offering discount cards for many prescription pre-natal vitamins. , Folic Acid , ...
Breaking Medicine News(10 mins):Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4
... Innovative technology such as electronic wristbands is developed to ... Human errors. Wristbands are developed which provides information about ... used in hospitals now to prescribe, dispense and administer ... bands contain electronic system which is similar to the ...
... the clinical trials involving lung cancer patients and it ... a frontline therapy for those with lung cancer. One ... regime in the elderly patients is the tolerability and ... tyrosine kinase inhibitor erlotinib (Tarceva) has demonstrated encouraging activity ...
... of Fair Trading is responsible for checking the profits ... to the NHS. They have to monitor that only ... should be reasonable. ,The Pharmaceutical Price Regulation ... legislates the agreement of the pricing and quality of ...
... out of deprivation from being in poverty and poor ... for heart disease is potentially denying// life saving preventive ... published ahead of print in the journal Heart. ... being allocated "primary preventive" treatment, is currently calculated using ...
... Mammography is used for early detection of breast cancer and ... year and self examination of the breasts for lumps every ... of cancer is necessary to start an early treatment which ... reported in the New England Journal of Medicine has shown ...
... called villi which increase the surface area of the intestine ... are covered in epithelial cells // which are constantly renewed ... top of the villi every day. ,Scientists found ... the bowel which, in healthy tissue, are immediately filled with ...
Cached Medicine News:Health News:Tarceva Found To Benefit Older Lung Cancer Patients 2Health News:Pharmaceutical industries grant for R&D to be monitored 2Health News:Deprivation Can Cause Undetected Heart Problems 2Health News:Digital Mammogram For Detection Of Breast Cancer In Women With Dense Breasts 2
(Date:7/30/2015)... , July 30, 2015 ... latest report titled, "Continuous Glucose Monitoring Systems Market: Global ... to the report, the global continuous glucose monitoring systems ... and is expected to reach US$ 788.4 Mn by ... period, 2015 to 2020. Global continuous glucose ...
(Date:7/30/2015)... July 30, 2015 ... report with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... Insight: Biosensors Market Development and Demand Forecast ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more about ...
(Date:7/30/2015)... July 30, 2015  Medimetriks Pharmaceuticals, Inc. announced ... Phase III clinical study for Ozenoxacin, a novel ... owns the exclusive U.S. rights to Ozenoxacin 1% ... at 44 centers with an emphasis on U.S. ... 2 months and older with a clinical diagnosis ...
Breaking Medicine Technology:Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3